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Objectives. Rapid and reliable neurological evaluation soon after carotid artery surgery is feasible with modern methods of
general anesthesia, but postoperative pain therapy remains a challenge. Use of opioids can mask neurological deficits. We
investigated whether superficial cervical plexus block reduced postoperative opioid consumption after carotid
endarterectomy.
Design. Prospective, randomised, double-blinded, placebo controlled trial.
Methods. 46 patients undergoing unilateral carotid endarterectomy under general anesthesia were randomized to either
superficial cervical block with ropivacaine (n¼ 23) or placebo (n¼ 23). A patient controlled analgesia device (PCA) de-
livering morphine was provided for all patients. Subjective pain levels (visual analog scale, VAS) were recorded. The pri-
mary outcome was total morphine consumption on discharge from the recovery room. Secondary outcomes included arterial
pCO2 (as an indicator of central nervous effects of morphine) and patient satisfaction.
Results. No adverse effects of the superficial cervical plexus block were reported. Four patients in the placebo group were
excluded because of other drug use post-operatively. Per protocol analysis compared 23 patients in ropivacaine group and
19 patients in the placebo group. The ropivacaine group had a significant reduction in morphine consumption (3.8 2.0
versus 12.9 4.0, p< 0.001), lower maximal pain scores (2.6 2.0 versus 5.8 1.6, p< 0.001), and paCO2 levels
(39.0 2.6 versus 41.9 3.4, p¼ 0.008) at discharge from the recovery room. Patient satisfaction (1¼ very good to
6¼ insufficient) was substantially higher in the ropivacaine group (1.7 0.7 versus 3.1 1.2, p< 00.01).
Conclusion. The significant and clinically relevant lower morphine consumption and pain score, as well as the substan-
tially higher patient satisfaction demonstrate that superficial cervical plexus block provides effective pain relief for patients
undergoing carotid endarterectomy.
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Reducing perioperative stress is critical to minimizing
cardiovascular complications, especially in patients
undergoing carotid surgery. Sufficient postoperative
pain therapy therefore is very important to achieving
a low complication rate. Performing the procedure
under general anaesthaesia with modern short acting
anaesthetics provides good intraoperative hemody-
namic stability, good operating conditions and rapid
recovery for immediate and reliable neurological
evaluation, but underlines the importance of
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relief a combination of general anaesthesia and re-
gional analgesic technique seems desirable. The aim
of this study was to test the hypothesis that superficial
cervical plexus block, with ropivacaine, would reduce
postoperative morphine consumption in patients
undergoing unilateral carotid endarterectomy under
general anaesthesia.
Material and Methods
Consecutive patients scheduled for elective, unilateral,
carotid artery surgery were recruited over a time
period of 6 months. Patients with chronic pain and/or
analgesic therapy before surgery, patients not capable
of using the visual analog scale (VAS scale), andrved.
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medication were excluded. The trial was approved
by the local ethical committee and all patients pro-
vided informed consent. A flow diagram of patients
through the trial is depicted in Fig. 1.
The procedure was performed with a standardised
general anesthetic regimen. Patients received 10 to
20 mg chlorazepate the evening before surgery, and
3.75 mg midazolam in the morning. Oral antihyper-
tensive therapy was continued until surgery. Anes-
thesia was induced with remifentanil, etomidate,
rocuronium and after tracheal intubation main-
tained with sevoflurane 0.5e1.5% and remifentanil
0.1e0.25 mg/kg/min. Patients were randomly assigned
to the ropivacaine or placebo group, using a previously
generated, continuous randomization list, kept in
a closed envelope by the first author. Before induction
of anesthesia the envelope was handed to an anesthe-
sia nurse not involved in the study and in the furthertreatment of the patient. She was asked to prepare
identical syringes either containing 10 ml Ropivacaine
10 mg/ml or 10 ml NaCl 0.9% solution according to
the randomisation number on the list. After induction
of anesthesia the superficial cervical plexus block was
performed. All persons involved in the anesthetic and
surgical management were blinded to the actual med-
ication (i.e. anesthesiologist, surgeon and recovery
room nurses). A 22G needle was inserted at the poste-
rior border of the sternocleidomastoid muscle at the
level of C4. Ropivacaine or identical saline placebo
was injected in cranial, caudal and dorsal direction.
During the procedure SSEP (somatosensory evoked
potentials) monitoring (Viking IV, Nicolet Biomedical
Inc. Madison, Wisconsin) of the median nerve was
performed to detect carotid clamp associated cerebral
ischaemia and any need for shunt insertion.
After admission to the recovery room a patient con-
trolled analgesia was provided (Graseby PCA 3300,Excluded (n= 0)
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patients an i.v. dosage of 1 mg Morphine without con-
tinuous rate and a five minute lock out time. Addi-
tional Morphine could be administered, if necessary.
No other analgesic drugs were used. Pain levels
were assessed every 15 minutes using a standard, con-
tinuous, horizontal, visual analogue scale. Patients
were asked to rate their pain on a VAS consisting of
a 10-cm line with the anchor points, ‘‘no pain’’ and
‘‘worst possible pain’’ shown in Fig. 2.1 At discharge
from the recovery room arterial pCO2 was docu-
mented and the patients asked to score the quality
of pain therapy between 1 (very good) and 6
(insufficient).
Power calculations showed that the minimum sam-
ple size required for demonstrating a 5 mg reduction
in morphine consumption was 26 patients, 13 patients
in each group (one sided test, a< 0.05, 1b> 0.8,
d¼ 5 mg, s¼ 5). Per protocol analysis of the differ-
ences between the groups in morphine consumption,
maximum pain level, pCO2 level and quality of pain
therapy were performed using Mann Whitney U
Test (SPSS, SPSS Inc. Chicago, USA). Values are given
as mean and standard deviation.
Results
The mean age of patients was 69 years (range 47 to 88
years), including 10 women (24%) and 36 men (76%).
Thirty-five Patients (83%) suffered from arterial
hypertension and had oral antihypertensive therapy.
Diabetes mellitus was diagnosed in 9 patients (21%).
Sixteen patients had coronary artery disease (38%), 3
of them had a history of myocardial infarction and 9
of cardiac surgery. Carotid artery disease was asymto-
matic in 24 patients, the other 22 had ipsilateral hemi-
spheric symptoms (transient n¼ 12; stroke n¼ 10).
The two randomized groups were well matched for
baseline factors (Table 1). Four patients of the control
group had to be excluded due to concurrent use of
non-steroidal anti-inflammatory drugs (NSAIDs) in
the recovery room. Twenty three patients of the ropi-
vacaine group and 19 patients of the placebo group
could be evaluated. Surgical technique was endarter-
ectomy with patch closure in 36 cases (ropivacaine
group n¼ 19, placebo group n¼ 17), eversion endar-
terectomy in 5 cases (ropivacaine group n¼ 3, placebo
group n¼ 2) and graft interposition in 1 case
Worst possible painNo pain
Fig. 2. VAS consisting of a 10-cm line with the anchor points,
‘‘no pain’’ and ‘‘worst possible pain’’.1Eur J Vasc Endovasc Surg Vol 33, January 2007(ropivacaine group). No shunts were used. No new
neurological deficits were observed within 24 hours
after surgery. One patient in the ropivacaine group
suffered a non-fatal myocardial infarction the day
after surgery. Complications due to the superficial
cervical plexus block, like hematoma, infection, lesion
of a neural structure intravascular or intrathecal
injection, impaired diaphragmatic function or allergic
reaction did not occur.
Patients were observed in the recovery room for
123 45 minutes. Total morphine consumption was
3.8 2.0 mg in the ropivacaine group and 12.9 4.0
in the placebo group (p< 0.001). In four patients of
the placebo group additional morphine (1e5 mg)
had to be administered. Maximum VAS score was
2.6 2.0 in the ropivacaine group versus 5.8 1.6 in
the placebo group (p< 0.001). Maximum VAS levels
were documented 52 29 minutes after admission
to the recovery room in the ropivacaine group, respec-
tively 26 17 minutes in the placebo group. Arterial
pCO2 levels at discharge from the recovery room
were 39.0 2.6 in the ropivacaine and 41.9 3.4 in
the placebo group ( p¼ 0.008). Patients in the ropiva-
caine group rated the quality of pain therapy
1.7 0.7 compared to 3.11.2 in the placebo group
(p< 0.01). The results are summarized in Table 2.
Discussion
In this randomized trial, we have demonstrated that
superficial cervical plexus block with ropivacaine
reduced more than 3-fold opioid consumption in the
recovery room. The high patient controlled morphine
demand in the placebo group stresses the need of an
appropriate pain therapy regimen for carotid surgery
patients. The impact on close surveillance, requiring
Table 1. Differences of age, sex, prevalence of risk factors for arte-
riosclerosis and clinical status of carotid disease between the
groups
Ropivacaine
Group (n¼ 23)
Placebo
Group (n¼ 23)
Age (mean SD) 69 6 70 8 p¼ 0.732a
Number of females (n) 5 5 p¼ 1.000b
Hypertension (n) 19 16 p¼ 0.318b
Diabetes mellitus (n) 5 4 p¼ 1.000b
Coronary artery
disease (n)
8 8 p¼ 1.000b
Asymtomatic
patients (n)
11 13 p¼ 0.773b
Patients with TIA (n) 6 6 p¼ 1.000b
Patients with
stroke (n)
5 5 p¼ 1.000b
a U-Test.
b Two tailed Fisher’s Exact Test.
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strated in this study design, but the difference in
pCO2 levels at discharge from the recovery room re-
flected central nervous effects and clinical relevance
of opioid administration. Additional use of NSAIDs,
which were explicitly excluded in this study, would
most likely further reduce opioid administration and
increase the proportion of patients who will not re-
quire opioids at all. There were no patients in the ro-
pivacaine group in which morphine requirements or
pain scores suggested that a satisfactory block had
not been achieved. This stresses the reliability of this
technique.
Indications for carotid endarterectomy have been
established by large randomised clinical studies.2e7
The benefits of surgery must outweigh the periopera-
tive risk.8e11 Achieving a low perioperative complica-
tion rate is challenging, given the major comorbidities
of these patients. The perioperative management for
carotid endarterectomy has to be refined by surgeons
and anesthesiologists. In this context advantages of
general versus regional anesthesia are being discus-
sed.12e18 So far there is no clear evidence for the supe-
riority of any single technique.19 The still ongoing
GALA trial might provide additional information on
this topic. However, the peri-operative complication
rate of each unit remains a relevant endpoint, how-
ever this is achieved.
Combining general and regional anesthesia for
postoperative pain therapy is well established in pae-
diatric anesthesia and major abdominal or thoracic
surgery, whenever the benefit outweighs the addi-
tional risk. Superficial cervical plexus block, for carotid
surgery, is an easy technique for blocking cutaneous
branches of the cervical plexus (great auricular nerve,
transverse cervical nerve, supraclavicular nerve and
lesser occipital nerve) at Erb’s point (punctum nervo-
sum), which is located on the posterior border of
the sternocleidomastoid muscle midway between its
attachments to the mastoid process, and the sternum
and clavicle. Carotid surgery may be performed dur-
ing superficial cervical plexus block alone providing
operating conditions comparable to deep cervical
Table 2. Maximum VAS score, total morphine consumption, arte-
rial pCO2 levels and patients rating of the quality of pain therapy
at discharge from the recovery room
Ropivacaine
Group (n¼ 23)
Placebo
Group (n¼ 19)
Maximum VAS score 2.6 2.0 5.8 1.6 p< 0.001
Morphine
consumption (mg)
3.8 2.0 12.9 4.0 p< 0.001
Arterial pCO2 (mmHg) 39.0 2.6 41.9 3.4 p¼ 0.008
Patient Satisfaction (1e6) 1.7 0.7 3.1 1.2 p< 0.001plexus block or combined deep and superficial
block.20e22 Both techniques need additional local infil-
tration by the surgeon. The equal efficacy of superficial
and deep/combined block may be explained by the
fact, that after an injection of dye for superficial
block e under the investing fascia of a cadaver e dye
can be found in the deep cervical space coating
cervical nerve roots,23 obviously because of the dis-
continuity of the investing layer of the deep cervical
fascia.24,25 This is not the case after a subcutaneous
injection. Therefore the term intermediate cervical
plexus block was suggested but is not in widespread
use.26 Compared to local wound infiltration superficial
cervical plexus block offers better analgesia, is simple
to perform and bears no additional risk. Bilateral
superficial cervical plexus block has been successfully
used for postoperative pain therapy after thyroid sur-
gery under general anesthesia.27 This combination
has not been reported previously for carotid surgery.
This trial showed that superficial cervical plexus
block was safe, easy to perform and an effective pro-
cedure to reduce morphine consumption and improve
pain relief after carotid endarterectomy under general
anesthesia.
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